SPECTRE (Eurostars)- PTA procedures in MRI
Nano4Imaging has been granted a project within the Eurostars program and will coordinate a collaboration between Fraunhofer Mevis (Bremen, DE), Radboud University Medical Centre (Nijmegen, NL) and Soteria Medical BV (Arnhem, NL) . The project acronym is SPECTRE and enables Nano4Imaging to construct and test robot-controlled PTA catheters for use in MRI procedures. Anticipated project start is december 1st 2017.
IMAGINE (BMBF)- Markers and instruments for MPI
Nano4Imaging has been granted a new project in a German-Turkish collaboration between BMBF and TUBITAK (2+ 2 project). The project acronym is IMAGINE and will allow Nano4Imaging to extend its MagnaFy technology to Magnetic Particle Imaging (MPI). The project is a collaboration with German partner UKSH (University Hospital in Lubeck) and two Turkish Partners, Aselsan and Bilkent University. The project will officially start October 1st 2017.
Open Mind (Horizon 2020)- customized production of medical devices
On september 1st 2015 Nano4Imaging has started an new Horizon project entitled OpenMind, lead by Fraunhofer IPT (Aachen), involving a total of 9 partners, including 6 SMEs to further develop and extend the production system for medical devices. The official program kick-off was on April 27th 2016 in Brussels, with the project officer and monitor. The project enables Nano4Imaging as enduser in the consortium, to further optimize the current production process for current and new MRI compatible instruments. Partners are Fraunhofer IPT (coordinator), Diribet, Blue Acre Technology, Tamponcolor, Gimac, ICS and Fond Politechnica Milano. The OPENMIND_brandbook can be downloaded here. The latest two newsletters can de downloaded from NewsletterN2 and Newsletter-N3.
Marie-Curie training network (iTERM)– contrast agents for MRI- completed
The overarching scientific objective of iTERM is the development of new materials and implants for the bio-engineering of soft tissue (skin, urogenital) and hard (bone) tissue as well as state-of-the-art novel multimodality visualisation procedures to monitor the implants. In collaboration with the research group on Experimental and Molecular Imaging (prof. Fabian Kiessling) at the Technical University of Aachen (RWTH), we developed new MRI contrast agents, based on hemin-derivatives. The project was coordinated by Radboud University Medical Centre in Nijmegen (Netherlands) and the final project meeting was on June 8th in Nijmegen.